Caricamento...
1,25D(3) enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models
BACKGROUND: 1,25 dihydroxyvitamin D(3) (1,25D(3)) potentiates the cytotoxic effects of several common chemotherapeutic agents. The combination of gemcitabine and cisplatin (GC) is a current standard chemotherapy regimen for bladder cancer. We investigated whether 1,25D(3) could enhance the antitumor...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2891990/ https://ncbi.nlm.nih.gov/pubmed/20564622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25059 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|